Catafau Ana M, Bullich Santiago, Danús Mónica, Penengo María M, Cot Albert, Abanades Sergio, Farré Magí, Pavía Javier, Ros Domènec
Experimental Medicine, Clinical Pharmacology Discovery Medicine, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Barcelona, Spain.
Synapse. 2008 Jan;62(1):62-9. doi: 10.1002/syn.20465.
123I-IBZM single photon emission computed tomography (SPECT) is a widely used method to measure D(2) receptor availability. However, test-retest variability and reliability have not been reported yet. This study aimed to further characterize 123I-IBZM SPECT in healthy volunteers (HVs), by assessing (1) pseudoequilibrium interval after bolus injection; (2) normal specific uptake ratio (SUR) values using filtered-backprojection (FBP); and the iterative reconstruction algorithm ordered-subsets expectation maximization (OSEM); (3) test-retest variability and reliability (intraclass correlation coefficient); and (4) influence of OSEM on test-retest variability and reliability.
Ten HVs (Group A) were scanned twice 48 h apart for test-retest variability and reliability measurements, and n = 4 of them were sequentially scanned over time. Eighteen HVs (Group B) were scanned once at pseudoequilibrium. For reconstruction FBP was used. Test-retest scans were reconstructed in addition using OSEM. SPECT-MRI coregistration was used for region of interest drawing.
Pseudoequilibrium was achieved at 90 min postinjection (p.i.) and maintained until the end of the SPECT session (n = 4), and mean SUR at this time point was 0.96 +/- 0.14 (Groups A + B, n = 28). Mean SUR at test was 0.96 +/- 0.19 and at retest 0.94 +/- 0.19 (Group A, n = 10). Using FBP, test-retest variability was (12.7 +/- 9.6)% and reliability was 0.74. Using OSEM with 18 equivalent iterations, test-retest variability and reliability were improved to (6.5 +/- 5.2)% and 0.84, respectively.
123I-IBZM SPECT imaging using the bolus injection and a single scan at 90 min p.i. is a reproducible method showing acceptable test-retest variability and reliability. Test-retest variability and reliability can be substantially improved using OSEM with 12-36 equivalent iterations.
123I-碘苄胍单光子发射计算机断层扫描(SPECT)是一种广泛用于测量D(2)受体可用性的方法。然而,重测变异性和可靠性尚未见报道。本研究旨在通过评估(1)静脉推注后的伪平衡期;(2)使用滤波反投影(FBP)和迭代重建算法有序子集期望最大化(OSEM)的正常特异性摄取率(SUR)值;(3)重测变异性和可靠性(组内相关系数);以及(4)OSEM对重测变异性和可靠性的影响,进一步描述健康志愿者(HV)中的123I-碘苄胍SPECT。
10名HV(A组)间隔48小时进行两次扫描,以测量重测变异性和可靠性,其中4名随时间顺序扫描。18名HV(B组)在伪平衡期进行一次扫描。重建采用FBP。重测扫描另外使用OSEM进行重建。SPECT-MRI配准用于感兴趣区绘制。
注射后90分钟(p.i.)达到伪平衡并维持到SPECT检查结束(n = 4),此时平均SUR为0.96±0.14(A组 + B组,n = 28)。测试时的平均SUR为0.96±0.19,重测时为0.94±0.19(A组,n = 10)。使用FBP时,重测变异性为(12.7±9.6)%,可靠性为0.74。使用18次等效迭代的OSEM时,重测变异性和可靠性分别提高到(6.5±5.2)%和0.84。
采用静脉推注并在注射后90分钟进行单次扫描的123I-碘苄胍SPECT成像是一种可重复的方法,显示出可接受的重测变异性和可靠性。使用12 - 36次等效迭代的OSEM可显著提高重测变异性和可靠性。